Chinese Drug Developer Connect Biopharmaceuticals Completes $55 Million Series B Round

Login to View

Connect Biopharmaceuticals, a clinical-stage biotech medicine developer, has completed a US$55 million series B round of financing, led by private equity Advantech Capital, according to a company announcement released today.

Continue reading with a China Money Network subscription

Join Now

Already have an account or paid subscription? Log in